Written questions - 9th parliamentary term Joanna KOPCIŃSKA
Members can submit a specific number of questions to the President of the European Council, the Council, the Commission and the Vice-President of the Commission/High Representative of the Union, for written answer. Rule 144, Annex III
Strategy for the development of biotechnology and biomanufacturing in the context of public health challenges in the EU
03-04-2024
E-000993/2024
Commission
Methodological criteria for evaluating the Europe’s Beating Cancer Plan
21-01-2024
E-000167/2024
Commission
List and transposition mechanism of critical medicines categories
26-12-2023
E-003764/2023
Commission
Shortages of paediatric drugs in winter 2023-24
28-08-2023
E-002450/2023
Commission
Recurrence of drug-resistant tuberculosis cases
21-06-2023
E-001995/2023
Commission
The European cancer imaging initiative and the GDPR
31-01-2023
E-000279/2023
Commission
Role of the EMA’s MSSG and the HMA in the context of the medicines shortage
26-01-2023
E-000249/2023
Commission
Principles of the third EU4Health work programme
11-10-2022
E-003334/2022
Commission
Recommendations on the use of antibiotic treatments in well-defined bacterial infections
29-09-2022
E-003242/2022
Commission
Council recommendations on cancer and budget
29-09-2022
E-003241/2022
Commission
Report on the use of medicines for COVID-19
14-09-2022
E-003076/2022
Commission
Provenance of strains of the updated COVID-19 vaccine
08-07-2022
P-002494/2022
Commission